Last reviewed · How we verify
NCT05003401
Leveraging Technological Advancements to Improve the Treatment of Trichotillomania
NA trial testing HabitAware Keen2 in Trichotillomania (Hair-Pulling Disorder) in 25 participants. Completed in 16 July 2024.
16 July 2024
Quick facts
| Lead sponsor | Johns Hopkins University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 17 November 2021 |
| Primary completion | 16 July 2024 |
| Estimated completion | 16 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- HabitAware Keen2
Conditions studied
- Trichotillomania (Hair-Pulling Disorder) — all drugs for Trichotillomania (Hair-Pulling Disorder) →
- Trichotillomania — all drugs for Trichotillomania →
- Hair Pulling — all drugs for Hair Pulling →
Sponsor
Johns Hopkins University
Who can join
18 and older, any sex, with Trichotillomania (Hair-Pulling Disorder) or Trichotillomania. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will examine the effect using the Keen 2 on hair pulling styles (automatic and focused), the severity of hair pulling behaviors, and related psychiatric symptoms. Given that the Keen2 is anticipated to increase awareness of pulling behavior (but not necessarily change pulling behavior), the investigators hypothesize that the Keen 2 will increase awareness of pulling behaviors and reduce automatic pulling behavior. The investigators will explore reductions in overall hair pulling severity and related psychiatric symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05003401
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trichotillomania (Hair-Pulling Disorder)
Currently open trials in the same condition.
- NCT05207085 — Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults · Phase 2 · recruiting
Other Johns Hopkins University trials
Trials by the same sponsor.
- NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
- NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
- NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
- NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
- NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05003401 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05003401.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing